The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis

November 13, 2023 updated by: Aynur Demirel, Hacettepe University

Erişkin Kistik Fibrozisli Bireylerde Kemik Mineral Yoğunluğunun Postür, Solunum Fonksiyonları ve Fonksiyonel Egzersiz Kapasitesi Üzerine Etkisi

The study was conducted in the age range of 18-45 December, who were diagnosed with Cystic fibrosis.

Study Overview

Status

Recruiting

Conditions

Detailed Description

60 voluntary patients who have signed the consent form will be included. Within the scope of the research the demographic information of the individuals will be recorded. Functional capacities of individuals With the Shuttle Walking Test at Increasing Speed, respiratory functions respiratory function test, with measurements of respiratory November muscle strength and endurance, the level of dyspnea was Modified Medical Peripheral November muscle strength hand dynamometers with Research Council (mMRC) Dyspnea Scale posture assessment with the Corbin Posture Analysis Scale, trunk mobility with the Trunk Pelvis-Hip Angle Test, core stabilization with Sahrmann's Core Stability Test, individuals' perception of cosmetic deformity Walter Reed visual assessment questionnaires

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey
      • Ankara, Turkey, 06100
        • Recruiting
        • Hacettepe University, Health Sciences Faculty
        • Contact:
        • Sub-Investigator:
          • Aysu Yalman
        • Sub-Investigator:
          • Naciye Vardar Yagli, PhD, Prof.
        • Sub-Investigator:
          • Oğuz Karcıoğlu, MD
        • Sub-Investigator:
          • Ebru Damadoglu, MD, Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients referred by the department of chest diseases of Hacettepe University will be taken

Description

Inclusion Criteria:

  • Patients aged between 18-45 who were diagnosed with Cystic Fibrosis

Exclusion Criteria:

In the last year, patients;

  • who had a fracture in any part of the patient's body
  • who had undergone spine surgery
  • who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
low bone mineral density
bone mineral density according to t and z score.
normal bone mineral density
bone mineral density according to t and z score.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Exercise Capacity
Time Frame: 1 day
Functional exercise capacity by incremental shuttle walk test in patients with adult Cystic Fibrosis
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posture
Time Frame: 1 day
posture by Corbin Posture Analysis Form in patients with adult Cystic Fibrosis
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Investigators

  • Principal Investigator: Aynur Demirel, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2023

Primary Completion (Estimated)

January 22, 2024

Study Completion (Estimated)

February 16, 2024

Study Registration Dates

First Submitted

October 12, 2023

First Submitted That Met QC Criteria

October 12, 2023

First Posted (Actual)

October 18, 2023

Study Record Updates

Last Update Posted (Actual)

November 14, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GO22/126

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cystic Fibrosis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe